The corona pandemic and multiple sclerosis : vaccinations and their implications for patients-Part 1: recommendations
© 2021. The Author(s)..
The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify the implications for patients with MS, especially regarding vaccination and to formulate appropriate recommendations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:92 |
|---|---|
| Enthalten in: |
Der Nervenarzt - 92(2021), 12 vom: 15. Dez., Seite 1276-1282 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 1: Empfehlungen |
|---|
| Beteiligte Personen: |
Monschein, Tobias [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 08.12.2021 Date Revised 12.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00115-021-01155-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327784199 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327784199 | ||
| 003 | DE-627 | ||
| 005 | 20231225201542.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00115-021-01155-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1092.xml |
| 035 | |a (DE-627)NLM327784199 | ||
| 035 | |a (NLM)34232359 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Monschein, Tobias |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The corona pandemic and multiple sclerosis |b vaccinations and their implications for patients-Part 1: recommendations |
| 246 | 3 | 3 | |a Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 1: Empfehlungen |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.12.2021 | ||
| 500 | |a Date Revised 12.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify the implications for patients with MS, especially regarding vaccination and to formulate appropriate recommendations | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Multiple sclerosis | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a SARS-CoV‑2 | |
| 650 | 4 | |a Vaccination | |
| 700 | 1 | |a Zrzavy, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Löbermann, Micha |e verfasserin |4 aut | |
| 700 | 1 | |a Winkelmann, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Berger, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Rommer, Paulus |e verfasserin |4 aut | |
| 700 | 1 | |a Hartung, Hans-Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Zettl, Uwe K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Der Nervenarzt |d 1947 |g 92(2021), 12 vom: 15. Dez., Seite 1276-1282 |w (DE-627)NLM000034320 |x 1433-0407 |7 nnns |
| 773 | 1 | 8 | |g volume:92 |g year:2021 |g number:12 |g day:15 |g month:12 |g pages:1276-1282 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00115-021-01155-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 92 |j 2021 |e 12 |b 15 |c 12 |h 1276-1282 | ||